Preferred Label : Fanconi anemia, complementation group d2;
Symbol : FANCD2;
CISMeF acronym : FACD; FAD2; FANCD; FANCD2; FA4;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Fanconi pancytopenia, type 4; Fanconi anemia, complementation group D; FAD2; FA4; FANCD; FACD;
Description : Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder that causes
genomic instability. Characteristic clinical features include developmental abnormalities
in major organ systems, early-onset bone marrow failure, and a high predisposition
to cancer. The cellular hallmark of FA is hypersensitivity to DNA crosslinking agents
and high frequency of chromosomal aberrations pointing to a defect in DNA repair (summary
by Deakyne and Mazin, 2011). For additional general information and a discussion of
genetic heterogeneity of Fanconi anemia, see 227650.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the Fanconi anemia, complementation group D2 gene (FANCD2, 613984.0001);
Neoplasia : Leukemia;
Laboratory abnormalities : Multiple chromosomal breaks; Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C; Deficient excision of UV-induced pyrimidine dimers in DNA; Prolonged G2 phase of cell cycle;
Prefixed ID : #227646;
Origin ID : 227646;
UMLS CUI : C3160738;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Related ORDO disease(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)